Octave® Receives $10 Million Grant from The Michael J. Fox Foundation to Develop and Validate  Biomarker Test for Parkinson’s Disease. Learn More

Mar 23rd, 2022

Improving quality of life and cost-effective care in multiple sclerosis (MS) remains a challenge. The MS care paradigm requires a comprehensive analysis and a new approach to care coordination, and measurement and management systems.

More on the systemic challenges facing MS from Octave Consultants, Dr. David R. Weinstein, Ph.D., and Dr. Ankit Gandhi, PharmD in American Health & Drug Benefits here: https://bit.ly/3IB9afu

Learn how Octave is enabling a new paradigm of care through our MS Precision Care solution: https://www.octavebio.com/our-solution

Get in Touch

Please reach out and we’ll be in touch soon.